LIFE SCIENCE EXECUTIVE OF THE YEAR
2023
RECOGNIZING LIFE SCIENCE EXECUTIVES WHO HAVE EXCELLED IN THEIR LEADERSHIP
Henrik Blou (HB) took over as Chief Executive Officer at Gubra on 1 June 2016 after holding the position of Chief Business Officer in the same company for seven months. The company, with its 150 employees, conducts contract research for some of the world's largest biotech and pharmaceutical companies and has been named a Gazelle company eight years in a row.
NOMINATION POINTS
-
HB recently led Gubra to a successful IPO on Nasdaq Copenhagen.
-
The climate is a matter of heart for HB and Gubra. Under HB's management, the company has thus taken the lead by not only donating 10% of the company's profits to environmentally focused and green purposes, but the company also won in 2020 - under HB's management - EY's Sustainability Prize for the company's ability to clearly communicate its position within CSR, as well as active contributions to ensure a better climate.
-
HB is a talented leader who has managed to create a clear "why" for his organisation.
-
HB has been instrumental in developing and executing the company's strategy with a focus on increased commercialization, and has thus managed to create considerable growth for Gubra – resulting in 8 gazelle awards in a row.
-
HB is an advocate for sharing knowledge - i.a. he and the company's Imaging Team have developed a database (NeuroPedia) which is made freely available to researchers in academia and industry within virtual neuroscience/3D imaging (transgenic expression mapping).
-
HB has landed multi-billion dollar deals with pharmaceutical companies, including Bayer, Boehringer-Ingelheim, Ferring Pharmaceuticals and many more.
-
HB has a leadership style that places great emphasis on cooperation and involvement, and he also possesses an exceptional ability to solve complex problems.
LIFE SCIENCE EXECUTIVE OF THE YEAR
Albright Partners A/S is proud to host and sponsor the "Life Science Executive of the Year" award in Denmark.
​
WHAT ARE THE OBJECVTIVES OF THE AWARD?
-
Recognize Life Science Executives who have excelled in providing demonstrated leadership that has been critical to the success of their organizations.
-
Promote excellence among Life Science Executives.
-
Encourage Life Science Executives to make a positive difference in the lives of their employees and stakeholders.
-
Promote good leadership governance and courage to challenge the status quo.
​
WHAT ARE THE CRITERIA THAT THE EXECUTIVES ARE MEASURED UPON?
LEADERSHIP
Demonstrated leadership of the organisation and self while setting a clear purpose.
​
IMPACT
Demonstrated impact on company, industry and/or business in general.
COLLABORATION
Demonstrated ability to collaborate with both internal and external stakeholders.
​
INNOVATION
Demonstrated courage to challenge the status quo.
​
TEAM DEVELOPMENT
Demonstrated ability to foster an environment wherein recruitment, diversity, development, and retention of employees are cultivated.
​
THE 2023 JURY
The jury that selected the winner consisted of 5 members:
​
-
Elise Hauge, EVP, Chief People and Communications Officer hos Lundbeck.
-
Dennis Schmidt Pedersen, CHRO & EVP hos LEO Pharma.
-
Christina Sonnenborg Bredal, Senior Vice President, Head of People & Organization hos Zealand Pharma.
-
Nikolaj Knudtzon, Head of Global HR and General Manager hos BK Medical.
-
Anu Kerns, EVP, People and Organization hos Bavarian Nordic.
Host: Henrik Brabrand, CEO at Albright Partners
Adam Steensberg
Britt Meelby
Jensen
Anders Thelborg
Mikael Engsig
Marianne Kock
Henrik Blou
THE PROCESS
1. RESEARCHING EXECUTIVE
NOMINEES
2. SHORTLISTING OUR
NOMINEES
3. REACHING OUT TO THE
NOMINEES
4. JUDGING & EVALUATING
NOMINEES
5. REACHING OUT TO THE WINNER